Nova Eye Medical Limited (ASX:EYE)
0.147
+0.002 (1.38%)
Mar 10, 2026, 11:20 AM AEST
Nova Eye Medical Balance Sheet
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Cash & Equivalents | 2.62 | 5.06 | 6.15 | 7.42 | 8 | 17.8 | Upgrade
|
| Cash & Short-Term Investments | 2.62 | 5.06 | 6.15 | 7.42 | 8 | 17.8 | Upgrade
|
| Cash Growth | 16.16% | -17.82% | -17.09% | -7.26% | -55.06% | -81.39% | Upgrade
|
| Accounts Receivable | 4.1 | 4.09 | 3.9 | 1.93 | 2.05 | 1.91 | Upgrade
|
| Other Receivables | - | 0.09 | 0.18 | 1.18 | 1.72 | 3.52 | Upgrade
|
| Receivables | 4.1 | 4.18 | 4.08 | 3.11 | 3.77 | 5.43 | Upgrade
|
| Inventory | 3.5 | 2.81 | 4.28 | 3.81 | 3.54 | 2.9 | Upgrade
|
| Prepaid Expenses | 0.34 | 0.27 | 0.23 | 0.27 | 0.28 | 0.2 | Upgrade
|
| Total Current Assets | 10.55 | 12.33 | 14.75 | 14.6 | 15.59 | 26.33 | Upgrade
|
| Property, Plant & Equipment | 3.12 | 3.36 | 3.9 | 2.36 | 2.95 | 3.51 | Upgrade
|
| Other Intangible Assets | 6.39 | 6.86 | 7.03 | 8.45 | 7.17 | 3.44 | Upgrade
|
| Long-Term Deferred Charges | 3.54 | 3.89 | 4.13 | 4.87 | 10.85 | 8.66 | Upgrade
|
| Other Long-Term Assets | - | 0.07 | 0.07 | 0.07 | 0.07 | 0.06 | Upgrade
|
| Total Assets | 23.67 | 26.5 | 29.88 | 30.36 | 36.63 | 41.99 | Upgrade
|
| Accounts Payable | 2.58 | 2.35 | 3.57 | 4.31 | 2.41 | 2 | Upgrade
|
| Accrued Expenses | - | 2.17 | 1.64 | 1.32 | 0.91 | 0.74 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | - | 1.42 | Upgrade
|
| Current Portion of Leases | 0.65 | 0.63 | 0.48 | 0.64 | 0.54 | 0.52 | Upgrade
|
| Other Current Liabilities | 2.47 | - | - | 0.01 | 0.01 | 0 | Upgrade
|
| Total Current Liabilities | 5.7 | 5.15 | 5.68 | 6.27 | 3.86 | 4.69 | Upgrade
|
| Long-Term Leases | 2.15 | 2.38 | 2.87 | 0.89 | 1.4 | 1.76 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | - | 0.97 | 0.14 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | - | 0.08 | Upgrade
|
| Total Liabilities | 7.85 | 7.54 | 8.55 | 7.17 | 6.23 | 6.66 | Upgrade
|
| Common Stock | 59.1 | 58.94 | 52.71 | 45.18 | 37.44 | 36.68 | Upgrade
|
| Retained Earnings | -43.11 | -39.75 | -30.69 | -21.9 | -6.6 | 0.89 | Upgrade
|
| Comprehensive Income & Other | -0.16 | -0.23 | -0.69 | -0.09 | -0.44 | -2.24 | Upgrade
|
| Shareholders' Equity | 15.82 | 18.97 | 21.33 | 23.19 | 30.4 | 35.34 | Upgrade
|
| Total Liabilities & Equity | 23.67 | 26.5 | 29.88 | 30.36 | 36.63 | 41.99 | Upgrade
|
| Total Debt | 2.79 | 3.02 | 3.35 | 1.53 | 1.94 | 3.7 | Upgrade
|
| Net Cash (Debt) | -0.17 | 2.04 | 2.8 | 5.89 | 6.06 | 14.1 | Upgrade
|
| Net Cash Growth | - | -27.27% | -52.41% | -2.79% | -57.05% | -84.72% | Upgrade
|
| Net Cash Per Share | -0.00 | 0.01 | 0.01 | 0.04 | 0.04 | 0.10 | Upgrade
|
| Filing Date Shares Outstanding | 285.17 | 284.71 | 229.06 | 190.33 | 145.58 | 143.69 | Upgrade
|
| Total Common Shares Outstanding | 285.17 | 284.15 | 228.82 | 190.33 | 145.58 | 143.69 | Upgrade
|
| Working Capital | 4.85 | 7.17 | 9.07 | 8.33 | 11.73 | 21.64 | Upgrade
|
| Book Value Per Share | 0.06 | 0.07 | 0.09 | 0.12 | 0.21 | 0.25 | Upgrade
|
| Tangible Book Value | 9.43 | 12.11 | 14.3 | 14.74 | 23.22 | 31.89 | Upgrade
|
| Tangible Book Value Per Share | 0.03 | 0.04 | 0.06 | 0.08 | 0.16 | 0.22 | Upgrade
|
| Machinery | - | 3.48 | 3.07 | 2.96 | 2.56 | 2.32 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.